1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Vitamin B6 catabolism and lung cancer risk : Results from the Lung Cancer Cohort Consortium (LC3)
(
- Contribution to journal › Article
- 2018
-
Mark
Universal intracellular biomolecule delivery with precise dosage control
(
- Contribution to journal › Article
- 2009
-
Mark
Expression of Alkaline Sphingomyelinase in Yeast Cells and Anti-inflammatory Effects of the Expressed Enzyme in a Rat Colitis Model.
(
- Contribution to journal › Article
-
Mark
Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine
2009) 50th International Conference on Bioscience of Lipids In Chemistry and Physics of Lipids 160. p.33-33(
- Contribution to journal › Published meeting abstract
-
Mark
Ezetimibe Inhibits Expression of Acid Sphingomyelinase in Liver and Intestine.
(
- Contribution to journal › Article
- 2007
-
Mark
Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis.
(
- Contribution to journal › Article
- 2006
-
Mark
Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity
(
- Contribution to journal › Article
-
Mark
Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells.
(
- Contribution to journal › Article
- 2005
-
Mark
Acid sphingomyelinase is induced by butyrate but does not initiate the anticancer effect of butyrate in HT29 and HepG2 cells
(
- Contribution to journal › Article
-
Mark
Functional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesis
(
- Contribution to journal › Article